敗血症診断の世界市場レポート 2025年

敗血症診断の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.2％で14億7,000万米ドルに成長します。予測期間中の成長は、迅速診断に対する需要の高まり、ヘルスケアインフラへの投資の増加、個別化医療への注目の高まり、抗菌薬耐性の蔓延の増加、次世代シーケンシングの利用の高まりに起因すると考えられます。予測期間中に予想される主な動向には、診断におけるAIの統合、バイオマーカーの技術的進歩、分子診断の進歩、自動化およびデジタル診断プラットフォームへのシフト、診断における人工知能の継続的進歩などがあります。

院内感染（HAI）の罹患率の上昇が敗血症診断市場の成長を促進すると予想されます。HAIとは、患者がヘルスケア施設に入院中または入院後に発症する感染症で、通常は入院後48時間以上経過した後に発症し、入院時には発症していなかったものを指します。HAIの増加は、抗生物質耐性の問題が大きくなっていることが主な原因です。ヘルスケア現場での抗生物質の乱用や誤用が耐性菌の発生を招き、感染症の治療を困難にしています。敗血症診断は、院内感染の早期発見を可能にし、タイムリーな治療と合併症の減少を可能にする病原体やバイオマーカーを特定することで、重要な役割を果たしています。例えば、2024年11月、オーストラリアヘルスケア福祉研究所（Australian Institute of Health and Welfare）は、2022-2023年に医療関連感染（HAC）が公立病院入院の2％、私立病院入院の0.8％で発生し、HAIが最も頻度の高い合併症であったと報告しました。その結果、院内感染発生率の上昇が敗血症診断市場を大きく牽引しています。

敗血症診断市場の主なプレーヤーは、従来の血液培養に頼ることなく、迅速かつ正確に敗血症を検出できる無培養診断システムなどの革新的ソリューションの開発に注力しています。無培養診断システムは、ポリメラーゼ連鎖反応（PCR）、次世代シークエンシング（NGS）、イムノアッセイなどの先進技術を活用し、血液、唾液、組織などの患者サンプルから直接病原体を同定します。例えば、2024年4月、スペインに本拠を置くDeepull Diagnostics S.L.社は、敗血症の早期発見のためのUllCORE診断システムを発売しました。この培養不要のマルチプレックスPCRプラットフォームは、敗血症やその他の急性感染症における病原体の迅速な同定を可能にします。このシステムは8mLの全血から微生物DNAを抽出し、わずか1時間で50の報告可能な結果を提供します。このシステムは、細菌、真菌、抗生物質耐性遺伝子を含む敗血症の原因となる病原体の95％を検出し、早期診断を改善し抗生物質の誤用を減らすと同時に、病院が抗菌薬耐性と闘うのを支援します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界敗血症診断PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の敗血症診断市場：成長率分析
• 世界の敗血症診断市場の実績：規模と成長, 2019-2024
• 世界の敗血症診断市場の予測：規模と成長, 2024-2029, 2034F
• 世界敗血症診断総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の敗血症診断市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 機器
• 血液培養培地
• アッセイキットと試薬
• ソフトウェア
• 世界の敗血症診断市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 微生物学
• 分子診断
• 免疫測定
• フローサイトメトリー
• その他のテクノロジー
• 世界の敗血症診断市場病原体別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細菌性敗血症
• 真菌性敗血症
• ウイルス性敗血症
• その他の病原体
• 世界の敗血症診断市場：方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自動診断
• 従来の診断
• 世界の敗血症診断市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 病理学および基準検査室
• 調査機関
• 世界の敗血症診断市場、製品別の機器のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自動分析装置
• ポイントオブケア（POC）検査装置
• マイクロ流体ベースのデバイス
• ポリメラーゼ連鎖反応（PCR）装置
• フローサイトメーター
• 世界の敗血症診断市場血液培養培地の製品別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 好気性血液培養培地
• 嫌気性血液培養培地
• 結核菌血液培養培地
• 小児用血液培養培地
• 真菌血液培養培地
• 世界の敗血症診断市場、製品別アッセイキットおよび試薬のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 酵素免疫測定（ELISA）キット
• ポリメラーゼ連鎖反応（PCR）アッセイキット
• 免疫測定試薬
• 分子診断試薬
• バイオセンサーベースのアッセイキット
• 世界の敗血症診断市場ソフトウェアのサブセグメンテーション、製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• データ管理ソフトウェア
• 検査情報システム（Lis）
• 人工知能（AI）ベースの診断ツール
• 予測分析ソフトウェア
• クラウドベースの診断プラットフォーム

第7章 地域別・国別分析

• 世界の敗血症診断市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の敗血症診断市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 敗血症診断市場：競合情勢
• 敗血症診断市場：企業プロファイル
  • Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Becton, Dickinson and Company
• Koninklijke Philips N.V.
• GE Healthcare
• Wolters Kluwer N.V.
• bioMerieux S.A.
• Bruker Corporation
• DiaSorin S.p.A.
• Cepheid Inc.
• Seegene Inc.
• Luminex Corporation
• T2 Biosystems Inc.
• Cytovale Inc.
• Accelerate Diagnostics Inc.
• Immunexpress Inc.
• Sepsis Alliance

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 敗血症診断市場2029：新たな機会を提供する国
• 敗血症診断市場2029：新たな機会を提供するセグメント
• 敗血症診断市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Sepsis diagnostics refers to a range of advanced technologies and tests designed to quickly detect the presence of sepsis, a critical condition that can lead to organ failure and death if not treated promptly. These diagnostic tools enable healthcare providers to assess the severity of sepsis and make timely, informed decisions to initiate appropriate treatments, ultimately improving patient survival rates.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main products in sepsis diagnostics include instruments, blood culture media, assay kits and reagents, and software. Instruments are medical devices used to rapidly analyze blood samples and detect pathogens, allowing for the early and accurate identification of sepsis and facilitating timely treatment. Sepsis diagnostics employ various technologies such as microbiology, molecular diagnostics, immunoassays, and flow cytometry to detect different types of pathogens, including bacterial, fungal, viral sepsis, and others. The diagnostic methods include both automated and conventional diagnostic approaches. These tools are used by various end-users, including hospitals and clinics, pathology and reference laboratories, and research institutes.

The sepsis diagnostics market research report is one of a series of new reports from The Business Research Company that provides sepsis diagnostics market statistics, including the sepsis diagnostics industry global market size, regional shares, competitors with the sepsis diagnostics market share, detailed sepsis diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the sepsis diagnostics industry. This sepsis diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sepsis diagnostics market size has grown strongly in recent years. It will grow from $0.99 billion in 2024 to $1.07 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth during the historic period can be attributed to the increasing incidence of sepsis, growing awareness about the importance of early diagnosis, rising healthcare expenditure, a growing prevalence of hospital-acquired infections, and the increasing adoption of point-of-care testing.

The sepsis diagnostics market size is expected to see strong growth in the next few years. It will grow to $1.47 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth during the forecast period can be attributed to the rising demand for rapid diagnostics, increasing investments in healthcare infrastructure, a growing focus on personalized medicine, the increasing prevalence of antimicrobial resistance, and the rising use of next-generation sequencing. Key trends expected in the forecast period include the integration of AI in diagnostics, technological advancements in biomarkers, progress in molecular diagnostics, a shift toward automated and digital diagnostic platforms, and the continued advancement of artificial intelligence in diagnostics.

The rising incidence of hospital-acquired infections (HAIs) is expected to drive growth in the sepsis diagnostics market. HAIs are infections that develop during or after a patient's stay in a healthcare facility, typically 48 hours or more after admission, and were not present at the time of admission. The increase in HAIs is largely due to the growing issue of antibiotic resistance. Overuse and misuse of antibiotics in healthcare settings have led to the development of resistant bacteria, making infections more difficult to treat. Sepsis diagnostics play a critical role by enabling early detection of hospital-acquired infections, identifying pathogens and biomarkers that allow for timely treatment and reduced complications. For instance, in November 2024, the Australian Institute of Health and Welfare reported that in 2022-2023, healthcare-associated infections (HACs) occurred in 2% of public hospital admissions and 0.8% of private hospital admissions, with HAIs being the most frequent complication. As a result, the rising incidence of hospital-acquired infections is significantly driving the sepsis diagnostics market.

Key players in the sepsis diagnostics market are focusing on the development of innovative solutions, such as culture-free diagnostic systems, to enable rapid and accurate detection of sepsis without relying on traditional blood cultures. Culture-free diagnostics leverage advanced technologies, including polymerase chain reaction (PCR), next-generation sequencing (NGS), or immunoassays, to identify pathogens directly from patient samples such as blood, saliva, or tissue. For example, in April 2024, Deepull Diagnostics S.L., a Spain-based company, launched the UllCORE diagnostic system for early sepsis detection. This culture-free, multiplex PCR platform provides rapid pathogen identification in sepsis and other acute infections. The system extracts microbial DNA from 8 mL of whole blood, offering 50 reportable results in just one hour. It detects 95% of sepsis-causing pathogens, including bacteria, fungi, and antibiotic resistance genes, helping hospitals combat antimicrobial resistance while improving early diagnosis and reducing antibiotic misuse.

In October 2024, Trinity Biotech plc, an Ireland-based medical laboratory company, acquired a 12.5% stake in Novus Diagnostics Ltd. for $2.5 million. This acquisition aims to accelerate the development and commercialization of Novus Diagnostics' rapid point-of-care diagnostic solutions, particularly its 15-minute bloodstream infection test. This rapid test is expected to significantly enhance sepsis diagnosis and improve patient outcomes by enabling faster and more accurate testing for bloodstream infections. Novus Diagnostics is an Ireland-based medical technology company developing diagnostic solutions for sepsis and other bloodstream infections.

Major players in the sepsis diagnostics market are Siemens Healthcare GmbH, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Koninklijke Philips N.V., GE Healthcare, Wolters Kluwer N.V., bioMerieux S.A., Bruker Corporation, DiaSorin S.p.A., Cepheid Inc., Seegene Inc., Luminex Corporation, T2 Biosystems Inc., Cytovale Inc., Accelerate Diagnostics Inc., Immunexpress Inc., Sepsis Alliance.

North America was the largest region in the sepsis diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sepsis diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sepsis diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sepsis diagnostics market consists of revenues earned by entities by providing services such as clinical consultation, rapid diagnostic testing solutions, point-of-care diagnostic solutions, biomarker testing, and molecular diagnostic testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The sepsis diagnostics market also includes sales of sepsis diagnostic test kits, automated blood culture systems, molecular diagnostic equipment, sepsis biomarker assay kits, and rapid diagnostic devices for infection detection. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sepsis Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sepsis diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sepsis diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sepsis diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Instruments; Blood Culture Media; Assay Kits And Reagents; Software
• 2) By Technology: Microbiology; Molecular Diagnostics; Immunoassays; Flow Cytometry; Other Technologies
• 3) By Pathogen: Bacterial Sepsis; Fungal Sepsis; Viral Sepsis; Other Pathogens
• 4) By Method: Automated Diagnostics; Conventional Diagnostics
• 5) By End-Users: Hospitals And Clinics; Pathology And Reference Laboratories; Research Institutes
• Subsegments:
• 1) By Instruments: Automated Analyzers; Point-Of-Care (PoC) Testing Devices; Microfluidic-Based Devices; Polymerase Chain Reaction (PCR) Instruments; Flow Cytometers
• 2) By Blood Culture Media: Aerobic Blood Culture Media; Anaerobic Blood Culture Media; Mycobacteria Blood Culture Media; Pediatric Blood Culture Media; Fungal Blood Culture Media
• 3) By Assay Kits And Reagents: Enzyme-Linked Immunosorbent Assay (ELISA) Kits; Polymerase Chain Reaction (PCR) Assay Kits; Immunoassay Reagents; Molecular Diagnostic Reagents; Biosensor-Based Assay Kits
• 4) By Software: Data Management Software; Laboratory Information Systems (LIS); Artificial Intelligence (AI)-Based Diagnostic Tools; Predictive Analytics Software; Cloud-Based Diagnostic Platforms
• Companies Mentioned: Siemens Healthcare GmbH; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sepsis Diagnostics Market Characteristics

3. Sepsis Diagnostics Market Trends And Strategies

4. Sepsis Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sepsis Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Sepsis Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Sepsis Diagnostics Market Growth Rate Analysis
• 5.4. Global Sepsis Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Sepsis Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Sepsis Diagnostics Total Addressable Market (TAM)

6. Sepsis Diagnostics Market Segmentation

• 6.1. Global Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Blood Culture Media
• Assay Kits And Reagents
• Software
• 6.2. Global Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microbiology
• Molecular Diagnostics
• Immunoassays
• Flow Cytometry
• Other Technologies
• 6.3. Global Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacterial Sepsis
• Fungal Sepsis
• Viral Sepsis
• Other Pathogens
• 6.4. Global Sepsis Diagnostics Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Automated Diagnostics
• Conventional Diagnostics
• 6.5. Global Sepsis Diagnostics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Pathology And Reference Laboratories
• Research Institutes
• 6.6. Global Sepsis Diagnostics Market, Sub-Segmentation Of Instruments, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Automated Analyzers
• Point-Of-Care (Poc) Testing Devices
• Microfluidic-Based Devices
• Polymerase Chain Reaction (Pcr) Instruments
• Flow Cytometers
• 6.7. Global Sepsis Diagnostics Market, Sub-Segmentation Of Blood Culture Media, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Aerobic Blood Culture Media
• Anaerobic Blood Culture Media
• Mycobacteria Blood Culture Media
• Pediatric Blood Culture Media
• Fungal Blood Culture Media
• 6.8. Global Sepsis Diagnostics Market, Sub-Segmentation Of Assay Kits And Reagents, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzyme-Linked Immunosorbent Assay (Elisa) Kits
• Polymerase Chain Reaction (Pcr) Assay Kits
• Immunoassay Reagents
• Molecular Diagnostic Reagents
• Biosensor-Based Assay Kits
• 6.9. Global Sepsis Diagnostics Market, Sub-Segmentation Of Software, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Management Software
• Laboratory Information Systems (Lis)
• Artificial Intelligence (Ai)-Based Diagnostic Tools
• Predictive Analytics Software
• Cloud-Based Diagnostic Platforms

7. Sepsis Diagnostics Market Regional And Country Analysis

• 7.1. Global Sepsis Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Sepsis Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sepsis Diagnostics Market

• 8.1. Asia-Pacific Sepsis Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sepsis Diagnostics Market

• 9.1. China Sepsis Diagnostics Market Overview
• 9.2. China Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sepsis Diagnostics Market

• 10.1. India Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sepsis Diagnostics Market

• 11.1. Japan Sepsis Diagnostics Market Overview
• 11.2. Japan Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sepsis Diagnostics Market

• 12.1. Australia Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sepsis Diagnostics Market

• 13.1. Indonesia Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sepsis Diagnostics Market

• 14.1. South Korea Sepsis Diagnostics Market Overview
• 14.2. South Korea Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sepsis Diagnostics Market

• 15.1. Western Europe Sepsis Diagnostics Market Overview
• 15.2. Western Europe Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sepsis Diagnostics Market

• 16.1. UK Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sepsis Diagnostics Market

• 17.1. Germany Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sepsis Diagnostics Market

• 18.1. France Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sepsis Diagnostics Market

• 19.1. Italy Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sepsis Diagnostics Market

• 20.1. Spain Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sepsis Diagnostics Market

• 21.1. Eastern Europe Sepsis Diagnostics Market Overview
• 21.2. Eastern Europe Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sepsis Diagnostics Market

• 22.1. Russia Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sepsis Diagnostics Market

• 23.1. North America Sepsis Diagnostics Market Overview
• 23.2. North America Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sepsis Diagnostics Market

• 24.1. USA Sepsis Diagnostics Market Overview
• 24.2. USA Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sepsis Diagnostics Market

• 25.1. Canada Sepsis Diagnostics Market Overview
• 25.2. Canada Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sepsis Diagnostics Market

• 26.1. South America Sepsis Diagnostics Market Overview
• 26.2. South America Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sepsis Diagnostics Market

• 27.1. Brazil Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sepsis Diagnostics Market

• 28.1. Middle East Sepsis Diagnostics Market Overview
• 28.2. Middle East Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sepsis Diagnostics Market

• 29.1. Africa Sepsis Diagnostics Market Overview
• 29.2. Africa Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sepsis Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Sepsis Diagnostics Market Competitive Landscape
• 30.2. Sepsis Diagnostics Market Company Profiles
  • 30.2.1. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Sepsis Diagnostics Market Other Major And Innovative Companies

• 31.1. Becton, Dickinson and Company
• 31.2. Koninklijke Philips N.V.
• 31.3. GE Healthcare
• 31.4. Wolters Kluwer N.V.
• 31.5. bioMerieux S.A.
• 31.6. Bruker Corporation
• 31.7. DiaSorin S.p.A.
• 31.8. Cepheid Inc.
• 31.9. Seegene Inc.
• 31.10. Luminex Corporation
• 31.11. T2 Biosystems Inc.
• 31.12. Cytovale Inc.
• 31.13. Accelerate Diagnostics Inc.
• 31.14. Immunexpress Inc.
• 31.15. Sepsis Alliance

32. Global Sepsis Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sepsis Diagnostics Market

34. Recent Developments In The Sepsis Diagnostics Market

35. Sepsis Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Sepsis Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Sepsis Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Sepsis Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34966_Sepsis_Diagnostics_GMR_2025